Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
12900 studies found for:    Encephalopathy
Show Display Options
RSS Create an RSS feed from your search for:
Encephalopathy
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: L-ornithine L-aspartate;   Drug: Rifaximin;   Drug: Placebo
2 Completed Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Albumin;   Drug: Sodium chloride 0.9%
3 Completed Cerebrovascular Reactivity in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention:
4 Unknown  Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Intervention: Drug: Lactulose
5 Recruiting A Multi-Center Cohort Study of Risk Factors and Outcomes of Encephalopathy of Prematurity in China
Condition: Encephalopathy
Intervention:
6 Unknown  Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Probiotics(VSL#3)
7 Completed Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
Condition: Hepatic Encephalopathy
Interventions: Drug: VSL#3;   Other: Placebo
8 Recruiting Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Drug: Flumazenil;   Drug: Placebo
9 Recruiting Metformin Experience on Minimal Hepatic Encephalopathy
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy
Interventions: Drug: Metformin;   Drug: Placebo
10 Terminated The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin
11 Recruiting Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
Condition: Encephalopathy, Hepatic
Interventions: Drug: Nitazoxanide;   Drug: Lactulose
12 Completed Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Dietary Supplement: Branched-chain amino acids;   Dietary Supplement: Maltodextrin
13 Completed Safety and Efficacy of Topiramate in Neonates With Hypoxic Ischemic Encephalopathy Treated With Hypothermia
Condition: Hypoxic Ischemic Encephalopathy
Intervention: Drug: Topiramate in newborns with hypoxic ischemic encephalopathy treated with therapeutic hypothermia
14 Recruiting Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy
Conditions: Neonatal Encephalopathy;   Hypoxic-ischemic Encephalopathy
Intervention: Other: Autologous umbilical cord blood cells
15 Completed Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate;   Drug: Lactose
16 Not yet recruiting Correlation of Risk Factors and Severity of Hypoxic-ischaemic Encephalopathy
Condition: Hypoxic Ischaemic Encephalopathy
Intervention: Other: risk factors
17 Recruiting Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy
Condition: Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy)
Intervention: Biological: Autologous cord blood cell therapy
18 Completed Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy
Conditions: Hepatic Cirrhosis;   Minimal Hepatic Encephalopathy
Interventions: Other: Auxiliary Treatment;   Dietary Supplement: Hyperproteic and fiber-rich diet;   Drug: Nitazoxanide
19 Completed Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: Albumin
20 Unknown  Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hypertension, Portal;   Liver Cirrhosis
Interventions: Drug: Erythromycin;   Drug: Neomycin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.